购物车
- 全部删除
- 您的购物车当前为空
6-Thio-2'-Deoxyguanosine (β-TGdR) 是一种核苷类似物和端粒酶底物,可以通过端粒酶掺入重新合成的端粒中。
为众多的药物研发团队赋能,
让新药发现更简单!
6-Thio-2'-Deoxyguanosine (β-TGdR) 是一种核苷类似物和端粒酶底物,可以通过端粒酶掺入重新合成的端粒中。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 193 | 现货 | |
5 mg | ¥ 493 | 现货 | |
10 mg | ¥ 690 | 现货 | |
25 mg | ¥ 1,530 | 现货 | |
50 mg | ¥ 2,530 | 现货 | |
100 mg | ¥ 3,820 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 543 | 现货 |
产品描述 | 6-Thio-2'-Deoxyguanosine (β-TGdR) is a nucleoside analog and telomerase substrate. |
体外活性 | 6-Thio-dG在表达端粒酶(telomerase)的人类癌细胞和表达hTERT的人类成纤维细胞中引起端粒功能障碍,并导致端粒逐渐缩短。在实验中测试的癌细胞中,6-thio-dG抑制细胞活性,其IC50值介于0.7至2.9 μM之间。[1] |
体内活性 | 在携带A549肺癌异种移植瘤的小鼠中,6-Thio-dG(2 mg/kg,腹腔注射)通过诱导端粒功能失常,降低了A549细胞的肿瘤形成能力。[1] |
细胞实验 | Cells are plated in growth media in 96-well plates. Cells are incubated for 1 week and treated with varying concentrations of 6-thio-dG and 6-thioguanine or DMSO every 3 days. The 96-well plates are analyzed according the manufacturer's directions for the CellTiterGlo luminescent cell viability assay to obtain IC50 values. The IC50 is defined as the concentration of drug at which 50% of the cells are inhibited by the drug. Sigmoidal dose–response curves are used to calculate IC50 values. All samples are analyzed in triplicate, and SDs are from two independent experiments.(Only for Reference) |
别名 | β-TGdR, 6-Thio-dG |
分子量 | 283.31 |
分子式 | C10H13N5O3S |
CAS No. | 789-61-7 |
Smiles | Nc1nc(=S)c2ncn([C@H]3C[C@H](O)[C@@H](CO)O3)c2[nH]1 |
密度 | 2.02g/cm3 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 52 mg/mL (183.5 mM) H2O: < 1 mg/mL (insoluble or slightly soluble) Ethanol: < 1 mg/mL (insoluble or slightly soluble) | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容